CEACAM1 downregulation is evident in colorectal [27] and prostate [28] carcinomas; and the expression of CEACAM1 in prostate cancer cells suppresses their growth in vivo due to inhibition of tumor angiogenesis [29]. The gene discussed is CEACAM1; the disease is prostate carcinoma.